1. Home
  2. ZGM vs CVM Comparison

ZGM vs CVM Comparison

Compare ZGM & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZGM

Zenta Group Company Limited Ordinary Shares

N/A

Current Price

$1.65

Market Cap

18.3M

ML Signal

N/A

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$1.64

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZGM
CVM
Founded
2019
1983
Country
Macau
United States
Employees
9
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
19.3M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ZGM
CVM
Price
$1.65
$1.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.3K
98.8K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.22
N/A
Revenue Growth
N/A
65.45
52 Week Low
$1.09
$0.23
52 Week High
$4.44
$13.48

Technical Indicators

Market Signals
Indicator
ZGM
CVM
Relative Strength Index (RSI) 51.33 24.72
Support Level $1.38 N/A
Resistance Level $1.87 $4.84
Average True Range (ATR) 0.17 0.32
MACD 0.02 -0.21
Stochastic Oscillator 71.79 3.11

Price Performance

Historical Comparison
ZGM
CVM

About ZGM Zenta Group Company Limited Ordinary Shares

Zenta Group Co Ltd is a professional services provider in Macau, offering industrial park consulting services, business investment consulting services through LIC, and the sale of fintech products and services through LFT. Its industrial park consulting services focus on the pre-development stage, assisting with applications and negotiations for industrial park projects with PRC government authorities, with plans to expand into post-development services through LMS. The business investment consulting services mainly involve assisting clients in acquiring equity stakes in technology firms, private equity management firms, and industrial park project firms, supported by third-party professionals. The Group operates in Macau and the PRC, generating the majority of its revenue from the PRC.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: